BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 9041202)

  • 1. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
    Relf M; LeJeune S; Scott PA; Fox S; Smith K; Leek R; Moghaddam A; Whitehouse R; Bicknell R; Harris AL
    Cancer Res; 1997 Mar; 57(5):963-9. PubMed ID: 9041202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK; Halsør EF
    Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of angiogenic factors in breast cancer.
    Locopo N; Fanelli M; Gasparini G
    Breast Cancer Res Treat; 1998; 52(1-3):159-73. PubMed ID: 10066080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma.
    Li Z; Shimada Y; Uchida S; Maeda M; Kawabe A; Mori A; Itami A; Kano M; Watanabe G; Imamura M
    Int J Oncol; 2000 Sep; 17(3):453-60. PubMed ID: 10938383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression.
    Kumar-Singh S; Weyler J; Martin MJ; Vermeulen PB; Van Marck E
    J Pathol; 1999 Sep; 189(1):72-8. PubMed ID: 10451491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.
    Samoto K; Ikezaki K; Ono M; Shono T; Kohno K; Kuwano M; Fukui M
    Cancer Res; 1995 Mar; 55(5):1189-93. PubMed ID: 7532545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
    Zhang H; Issekutz AC
    Am J Pathol; 2002 Jun; 160(6):2219-30. PubMed ID: 12057924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
    Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC
    Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer.
    Anan K; Morisaki T; Katano M; Ikubo A; Kitsuki H; Uchiyama A; Kuroki S; Tanaka M; Torisu M
    Surgery; 1996 Mar; 119(3):333-9. PubMed ID: 8619189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel in vitro assay for human angiogenesis.
    Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR
    Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.
    Mise M; Arii S; Higashituji H; Furutani M; Niwano M; Harada T; Ishigami S; Toda Y; Nakayama H; Fukumoto M; Fujita J; Imamura M
    Hepatology; 1996 Mar; 23(3):455-64. PubMed ID: 8617424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Rogala E; Skopińska-Rózewska E; Sommer E; Pastewka K; Chorostowska-Wynimko J; Sokolnicka I; Kazoń M
    Anticancer Res; 2001; 21(6B):4259-63. PubMed ID: 11908679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in endometriosis and angiogenic factors.
    Fujimoto J; Sakaguchi H; Hirose R; Wen H; Tamaya T
    Gynecol Obstet Invest; 1999; 48 Suppl 1():14-20. PubMed ID: 10559660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor.
    Viglietto G; Romano A; Maglione D; Rambaldi M; Paoletti I; Lago CT; Califano D; Monaco C; Mineo A; Santelli G; Manzo G; Botti G; Chiappetta G; Persico MG
    Oncogene; 1996 Aug; 13(3):577-87. PubMed ID: 8760299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiogenic growth factor combinations on retinal endothelial cells.
    Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
    Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
    Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Cox J; Krammer B; Gatter KC; Harris AL
    Clin Exp Metastasis; 1999; 17(7):545-54. PubMed ID: 10845553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of circulating angiogenic factors in cancer patients.
    Poon RT; Fan ST; Wong J
    J Clin Oncol; 2001 Feb; 19(4):1207-25. PubMed ID: 11181687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.